Nearly two-thirds of patients with colorectal cancer indicate financial burdens
the ONA take:
According to a new study published in the journal Medical Care, researchers at the University of Michigan Comprehensive Cancer Center in Ann Arbor, Michigan, have found that about 62% of patients with colorectal cancer report some form of financial burden as a result of their cancer treatment.
For the study, the researchers surveyed 956 patients who had been treated for stage 3 colorectal cancer. Based on seven questions about financial burden, 29% indicated one to two areas of burden, 23% indicated three to four areas of burden, and 9% indicated 5 or more burdens. The questions referred to whether the patients had used savings, borrowed money, missed bill payments, or cut back spending on items like food, clothing, or activities.
The researchers found that the financial burden was highest among patients who received chemotherapy. In addition, younger, working patients with low-incomes were more likely to experience financial burdens as they could not afford to take time off from their jobs.
Their findings suggest that policy changes should be urged to allow support for patients who need time off from work to receive cancer care. The researchers recommend that patients speak with their physicians about their financial concerns.
About 62% of patients with colorectal cancer report some form of financial burden.
Nearly two-thirds of patients treated for colorectal cancer reported some measure of financial burden due to their treatment, according to a new study from researchers at the University of Michigan Comprehensive Cancer Center. The burden was greatest among patients who received chemotherapy and among younger patients who worked in low-paying jobs.
The study surveyed 956 patients who had been treated for stage 3 colorectal cancer. Among this group, chemotherapy is known to increase survival by up to 20 percent and is routinely recommended following surgery.
Sign Up for Free e-newsletters
- Distress, Neuroticism Predict Long-term Emotional Distress After Cancer Diagnosis
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- Patient Satisfaction Ratings Can Be Negatively Impacted by Nurse Staffing Ratio
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
- Bacteria in Probiotics Carry Potential Risks for Immunocompromised Patients
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
- Overall Survival Prolonged With HIPEC + Cytoreductive Surgery for Gastric Cancer
- Better Postoperative Outcomes With RAMIE for Esophageal Cancer
- Distinct Patterns of Shiny White Streaks Strong Indicator of Melanoma
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|